Progression-free survival (PFS), time-to-progression (TTP) and overall survival (OS) are commonly used endpoints in randomised controlled trials (RCTs) and observational studies of treatments for ...

Factors such as ECOG score and methotrexate response more strongly predicted progression-free and overall survival than epilepsy status in PCNSL.

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in ...

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

Now released, the data show the drug extended progression-free survival (PFS ... The drug has yet to demonstrate overall survival (OS) benefits either as a first- or second-line treatment.

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

overall response rate, disease progression-free survival and overall survival. After failing one to three therapies, 21 ...

Merck (NYSE:MRK) shares inched higher on Friday after Summit Therapeutics (NASDAQ:SMMT) announced the latest survival data ...

Patients in the ivonescimab group demonstrated a significantly greater progression-free survival than those in the ...

AstraZeneca’s Calquence has been shown to improve progression-free survival in previously untreated mantle cell lymphoma (MCL), with an unprecedented trend towards improved overall survival for ...

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

beating BeiGene’s PD-1 Tevimbra in their respective combinations with chemotherapy in first-line squamous non-small cell lung cancer on progression-free survival. To put the 22.3% overall ...